GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
27 hedge funds and large institutions have $8.72M invested in GeneDx Holdings Warrant in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 9 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
18% less funds holding
Funds holding: 33 → 27 (-6)
36% less capital inflows, than outflows
Capital inflows: $1.79M | Capital outflows: $2.79M
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LMR Partners
London,
United Kingdom
|
+$1.15M |
| 2 |
Gagnon Securities
New York
|
+$206K |
| 3 |
Ionic Capital Management
New York
|
+$196K |
| 4 |
Islet Management
New York
|
+$144K |
| 5 |
Weiss Asset Management
Boston,
Massachusetts
|
+$69.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sachem Head Capital Management
New York
|
-$1.13M |
| 2 |
Linden Advisors
New York
|
-$661K |
| 3 |
Diameter Capital Partners
New York
|
-$307K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$276K |
| 5 |
Jefferies Group
New York
|
-$174K |
WGSWW Hedge Fund Activity: Q1 2022 in Review
27 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q1 2022, worth a combined $8.72M — up 21% from $7.21M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of WGSWW and 3 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was LMR Partners, adding an estimated $1.15M. The largest seller was Sachem Head Capital Management, exiting entirely with an estimated $1.13M sold.
- 27 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q1 2022, down from 33 in Q4 2021.
- Funds reported $8.72M of GeneDx Holdings Warrant stock for Q1 2022, up 21% quarter-over-quarter.
- 3 funds opened new GeneDx Holdings Warrant positions in Q1 2022 and 9 closed out, a net change of -6 holders.
- The largest GeneDx Holdings Warrant buyer in Q1 2022 was LMR Partners, an estimated $1.15M added.
- The largest GeneDx Holdings Warrant seller in Q1 2022 was Sachem Head Capital Management, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2022.